Literature DB >> 31801972

Tumor propagating cells: drivers of tumor plasticity, heterogeneity, and recurrence.

Alexandre Teixeira Vessoni1, Eduardo Cremonese Filippi-Chiela2, Guido Lenz3, Luis Francisco Zirnberger Batista4,5,6.   

Abstract

Tumorigenesis is associated with the development of a highly variable pattern of cellular diversity, consequence of genetic and epigenetic diversification, followed by clonal selection and expansion. This process is shaped by the microenvironment and leads to intratumoral heterogeneity, which is characterized by differences between cancer cells in terms of gene expression, phenotypic markers, growth dynamics, and resistance to treatment. Another relevant aspect in intratumor heterogeneity is cell plasticity-the ability of a cell to switch to new identities. In this review, we focus on the mechanisms that regulate cancer cell plasticity within a tumor, and explore the concept of tumor propagating cells, or TPCs, a cancer cell able to propagate/phenocopy the parental tumor and recapitulate tumor heterogeneity. We discuss the influence of the microenvironment and driver mutations on TPCs formation and function, the existence of phenotypically distinct TPC clones within a tumor, the evolution of TPCs with disease progression, and their implications for therapy.

Entities:  

Mesh:

Year:  2019        PMID: 31801972     DOI: 10.1038/s41388-019-1128-4

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  67 in total

1.  Etiology of rabbit haemorrhagic disease spontaneously occurring in Korea.

Authors:  J H Park; H Kida; K Ueda; K Ochiai; M Goryo; C Itakura
Journal:  Zentralbl Veterinarmed B       Date:  1991-12

2.  In vitro insulin-like actions of human growth hormone: a study with an insulin antibody.

Authors:  L G Frigeri; K Teguh; U J Lewis
Journal:  Horm Metab Res       Date:  1987-10       Impact factor: 2.936

Review 3.  Neuroanatomy.

Authors:  E W Lauer
Journal:  Prog Neurol Psychiatry       Date:  1972

4.  [Estimation of the colloidal gold clearance in patients suffering from hypersplenism].

Authors:  K Kostić; Z Rolović; D Bosković; D Adamov
Journal:  Med Pregl       Date:  1972

5.  Tranylcypromine: a potent insulin secretagogue and hypoglycemic agent.

Authors:  R Bressler; M Vargas-Cord; H E Lebovitz
Journal:  Diabetes       Date:  1968-10       Impact factor: 9.461

6.  Sites of interaction of calmodulin with trifluoperazine and glucagon.

Authors:  R F Steiner; L Marshall
Journal:  Arch Biochem Biophys       Date:  1985-07       Impact factor: 4.013

7.  Punctuated evolution of prostate cancer genomes.

Authors:  Sylvan C Baca; Davide Prandi; Michael S Lawrence; Juan Miguel Mosquera; Alessandro Romanel; Yotam Drier; Kyung Park; Naoki Kitabayashi; Theresa Y MacDonald; Mahmoud Ghandi; Eliezer Van Allen; Gregory V Kryukov; Andrea Sboner; Jean-Philippe Theurillat; T David Soong; Elizabeth Nickerson; Daniel Auclair; Ashutosh Tewari; Himisha Beltran; Robert C Onofrio; Gunther Boysen; Candace Guiducci; Christopher E Barbieri; Kristian Cibulskis; Andrey Sivachenko; Scott L Carter; Gordon Saksena; Douglas Voet; Alex H Ramos; Wendy Winckler; Michelle Cipicchio; Kristin Ardlie; Philip W Kantoff; Michael F Berger; Stacey B Gabriel; Todd R Golub; Matthew Meyerson; Eric S Lander; Olivier Elemento; Gad Getz; Francesca Demichelis; Mark A Rubin; Levi A Garraway
Journal:  Cell       Date:  2013-04-25       Impact factor: 41.582

Review 8.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

9.  Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing.

Authors:  Marco Gerlinger; Stuart Horswell; James Larkin; Andrew J Rowan; Max P Salm; Ignacio Varela; Rosalie Fisher; Nicholas McGranahan; Nicholas Matthews; Claudio R Santos; Pierre Martinez; Benjamin Phillimore; Sharmin Begum; Adam Rabinowitz; Bradley Spencer-Dene; Sakshi Gulati; Paul A Bates; Gordon Stamp; Lisa Pickering; Martin Gore; David L Nicol; Steven Hazell; P Andrew Futreal; Aengus Stewart; Charles Swanton
Journal:  Nat Genet       Date:  2014-02-02       Impact factor: 38.330

10.  Massive genomic rearrangement acquired in a single catastrophic event during cancer development.

Authors:  Philip J Stephens; Chris D Greenman; Beiyuan Fu; Fengtang Yang; Graham R Bignell; Laura J Mudie; Erin D Pleasance; King Wai Lau; David Beare; Lucy A Stebbings; Stuart McLaren; Meng-Lay Lin; David J McBride; Ignacio Varela; Serena Nik-Zainal; Catherine Leroy; Mingming Jia; Andrew Menzies; Adam P Butler; Jon W Teague; Michael A Quail; John Burton; Harold Swerdlow; Nigel P Carter; Laura A Morsberger; Christine Iacobuzio-Donahue; George A Follows; Anthony R Green; Adrienne M Flanagan; Michael R Stratton; P Andrew Futreal; Peter J Campbell
Journal:  Cell       Date:  2011-01-07       Impact factor: 41.582

View more
  11 in total

Review 1.  The cellular origins of cancer with particular reference to the gastrointestinal tract.

Authors:  Malcolm R Alison
Journal:  Int J Exp Pathol       Date:  2020-08-14       Impact factor: 1.925

Review 2.  Intratumoral Heterogeneity in Differentiated Thyroid Tumors: An Intriguing Reappraisal in the Era of Personalized Medicine.

Authors:  Antonio Ieni; Roberto Vita; Cristina Pizzimenti; Salvatore Benvenga; Giovanni Tuccari
Journal:  J Pers Med       Date:  2021-04-23

Review 3.  CSC Radioresistance: A Therapeutic Challenge to Improve Radiotherapy Effectiveness in Cancer.

Authors:  María Auxiliadora Olivares-Urbano; Carmen Griñán-Lisón; Juan Antonio Marchal; María Isabel Núñez
Journal:  Cells       Date:  2020-07-09       Impact factor: 6.600

Review 4.  Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy.

Authors:  Yuanjun Lu; Yau-Tuen Chan; Hor-Yue Tan; Sha Li; Ning Wang; Yibin Feng
Journal:  Mol Cancer       Date:  2020-04-27       Impact factor: 27.401

Review 5.  Epithelial-Mesenchymal Transition and MicroRNAs in Colorectal Cancer Chemoresistance to FOLFOX.

Authors:  Paula I Escalante; Luis A Quiñones; Héctor R Contreras
Journal:  Pharmaceutics       Date:  2021-01-08       Impact factor: 6.321

Review 6.  CD73, Tumor Plasticity and Immune Evasion in Solid Cancers.

Authors:  Haitang Yang; Feng Yao; Paul F Davis; Swee T Tan; Sean R R Hall
Journal:  Cancers (Basel)       Date:  2021-01-07       Impact factor: 6.639

7.  Multi-parametric characterization of drug effects on cells.

Authors:  Yael Paran; Yuvalal Liron; Sarit Batsir; Nicola Mabjeesh; Benjamin Geiger; Zvi Kam
Journal:  F1000Res       Date:  2020-10-05

8.  Insights into Intra-Tumoral Heterogeneity: Transcriptional Profiling of Chemoresistant MPM Cell Subpopulations Reveals Involvement of NFkB and DNA Repair Pathways and Contributes a Prognostic Signature.

Authors:  Mario Cioce; Andrea Sacconi; Harvey I Pass; Claudia Canino; Sabrina Strano; Giovanni Blandino; Vito Michele Fazio
Journal:  Int J Mol Sci       Date:  2021-11-08       Impact factor: 5.923

9.  Simulating the Dynamic Intra-Tumor Heterogeneity and Therapeutic Responses.

Authors:  Yongjing Liu; Cong Feng; Yincong Zhou; Xiaotian Shao; Ming Chen
Journal:  Cancers (Basel)       Date:  2022-03-24       Impact factor: 6.639

Review 10.  Role of Exosomal miRNAs and the Tumor Microenvironment in Drug Resistance.

Authors:  Patrick Santos; Fausto Almeida
Journal:  Cells       Date:  2020-06-11       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.